Özet:

Purpose: The aim of this study is to evaluate the clinical characteristics of patients referred to in the post-infection laboratory of coronavirus disease-2019 [coronavirus disease-2019 (COVID-19)]. Instruments and Methods: Patients who were diagnosed with severe acute respiratory syndrome-CoV-2 (SARS-CoV-2) between 11 March 2020 and 11 March 2021, with neuromuscular symptoms and findings, referred to the ENMG laboratory, the hospital files were scaned retrospectively. Patients’ demographic information, comorbidities, complaints, SARS-CoV-2 infection date, desired electrophysiological examination and ENMG results were recorded. Results: A thousand two hundred and seventy-four patient files were scanned and 62 patients were included in the study [medium age: 50,39±17,2, 58,1% (n=36) men]. Patients were diagnosed with COVID-19 in an average of 7.29 ± 1.59 months after the beginning of the pandemic, most of which were not treated in intensive care (95.2%). Patients' neuromuscular complaints began at an average of 2.65±1.86 months after COVID-19 infection. The common symptoms were paresthesia (41.9%) and pain in the limbs (17.7%) The most common complications were hypertension (22.6 percent) and diabetes mellitus (17.7 percent). In 30.6 percent of patients, sensory disorders, reduced muscle strength and profound tendon reflection changes were detected. The most common diagnosis of ENMG was polyneuropathy (22.5%). In 42.1 percent of patients, the findings of ENMG were found within normal limits. The result: COVID-19, can lead to many neurological complications, including the peripheral nervous system (PSS). In patients with continued PSS complaints even if the initial electrophysiological assessments are normally identified, the need for repeated ENMG and more sensitive electrophysiological tests should also be taken into account. In future studies, it is necessary to investigate whether SARS-CoV-2 infection has a real effect on the formation of PSS pathologies.

Anahtar Kelimeler: